Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Haas

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 7, 2020
Interplay Between Statins, Cav1 (Caveolin-1), and AldosteroneAndrea V Haas, Rene Baudrand, Rebecca M Easly, et al.
Plos One|January 26, 2024
Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent modelsXiaojun Wang, Xiaohong Yu, Kostas Gavardinas, et al.
Pharmacology Research & Perspectives|February 23, 2022
Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat modelsXiaojun Wang, Yanping Xu, Xiaohong Yu, et al.
The Journal of Biological Chemistry|January 17, 2013
Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretionRebecca R Miles, William Perry, Joseph V Haas, et al.
Physiological Genomics|September 19, 2019
Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndromeLydia Coulter Kwee, Megan L Neely, Elizabeth Grass, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2018
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trialKatherine R Tuttle, Frank C Brosius, Sharon G Adler, et al.
Nature|May 8, 2024
Discovery of potent small-molecule inhibitors of lipoprotein(a) formationNuria Diaz, Carlos Perez, Ana Maria Escribano, et al.
The Journal of Physical Chemistry Letters|June 1, 2026
Single-Particle X-ray Scattering Reveals a High Local Supersaturation of Precursors as the Origin of CoO Assembly FormationSani Y Harouna-Mayer, Lars Klemeyer, Cecilia A Zito, et al.
Ebiomedicine|June 28, 2024
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer culturesTheresa E Schäfer, Lisanne I Knol, Ferdinand V Haas, et al.
Journal of Medicinal Chemistry|October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|August 7, 2020
Interplay Between Statins, Cav1 (Caveolin-1), and AldosteroneAndrea V Haas, Rene Baudrand, Rebecca M Easly, et al.
Plos One|January 26, 2024
Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent modelsXiaojun Wang, Xiaohong Yu, Kostas Gavardinas, et al.
Pharmacology Research & Perspectives|February 23, 2022
Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat modelsXiaojun Wang, Yanping Xu, Xiaohong Yu, et al.
The Journal of Biological Chemistry|January 17, 2013
Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretionRebecca R Miles, William Perry, Joseph V Haas, et al.
Physiological Genomics|September 19, 2019
Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndromeLydia Coulter Kwee, Megan L Neely, Elizabeth Grass, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2018
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trialKatherine R Tuttle, Frank C Brosius, Sharon G Adler, et al.
Nature|May 8, 2024
Discovery of potent small-molecule inhibitors of lipoprotein(a) formationNuria Diaz, Carlos Perez, Ana Maria Escribano, et al.
The Journal of Physical Chemistry Letters|June 1, 2026
Single-Particle X-ray Scattering Reveals a High Local Supersaturation of Precursors as the Origin of CoO Assembly FormationSani Y Harouna-Mayer, Lars Klemeyer, Cecilia A Zito, et al.
Ebiomedicine|June 28, 2024
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer culturesTheresa E Schäfer, Lisanne I Knol, Ferdinand V Haas, et al.
Journal of Medicinal Chemistry|October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Pageof 9